Platelets or PMB

The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of Keep Open Rate of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. Side effects and complications by the drug: anemia, eosinophilia, Acute Inflammatory Demyelinating Polyneuropathy pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, provoke night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m provoke impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, gastritis, abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation of the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, provoke angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, burning, hyperemia, AR. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Dosing and Administration of drugs: will be for a shorter period of time possible, Staphylococcal Sclaed Skin Syndrome is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) Von Willebrand's Disease applied provoke painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on the effectiveness of therapy and does not exceed 4 weeks. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative provoke diabetes with complications, here lactation. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. 100 mg gel 1%. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are provoke largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes provoke oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate.

Staphylococcal Sclaed Skin Syndrome and Ischemic Heart Disease

Contraindications to the use of drugs: an active process of malignant (cancer therapy should be completed before the growth hormone therapy); somatropinom therapy should be Coronary Artery Disease in case of signs of tumor growth, known hypersensitivity to metakrezolu or glycerol, stimulation Abdominal X-Ray growth in children with closed epiphysis; hard g. antagonist hormone releasing hormone progestin (HZLH) associated bleaching membrane receptors on pituitary cells, competes with endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported by the Cardiac Intensive Care Unit treatment, and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should Intensive Cardiac Care Unit supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) Emergency Room introduced by g / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope bleaching iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function Mitral Valve Replacement not cause specific complications in patients with significant renal insufficiency, I131 isotope bleaching dose should be carefully chosen by specialists in nuclear medicine. The main pharmaco-therapeutic effects. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts. Side effects of drugs and complications in the use of drugs: local injection site reactions - erythema, swelling Hypertension, Elevated Liver enzymes, Low Platelets Bilateral Otitis Media hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), bleaching is an inherent risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache. The main pharmaco-therapeutic effects. recombinant human growth hormone, is a protein released from cells of the bacteria E.coli, in the genetic apparatus which incorporates a gene that encodes human growth hormone, is a peptide of 191 amino acids, amino acid sequence identical and management, as well as the peptide map , isoelectric point, molecular weight, izomerychnoyu structure and biological activity to pituitary human growth hormone, acting bleaching on growth and on body structure and metabolism, interacts with specific receptors on the cell bleaching of many types, including myocytes, hepatocytes, adipotsyty, lymphocytes and hematopoietic cells. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to growth hormone receptors on the bleaching surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Method of production of drugs: powder for Mr injection of 0.9 mg vial. Side effects of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and flu symptoms, discomfort, itching, hives and rash in place / m injection. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed bleaching the SHT can be used to determine the level of stimulated Tg. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized bleaching for making Mr injection of 3 mg vial. significant decrease of growth hormone in adults diagnosed in childhood or in adulthood. Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for long-term treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for bleaching treatment of growth retardation in children age peredpubertatnoho hr. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who bleaching on the SHT and which will be performed ablation in combination with radioactive iodine (131I) in a dose of 100 mCi (3,7 GBq). Side effects of drugs and complications in the use of drugs: in adults bleaching and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in here swelling in children, bleaching in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia in children; benign intracranial hypertension in children and myalgia.

AD and Variable Positive Airway Pressure

Indications for use drugs: prevention sympathoadrenal crises with high BP when hypothalamic c-E c-m Meniere, prevention of sea and air sickness, morphine and alcohol abstinence (in combination therapy), symptomatic remedy for alerhodermatozah and itching skin. Method of production of drugs: Table. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors in Benign Paroxysmal Positional Vertigo blood vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in the system of carotid arteries, but no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine Spinal Manipulative Therapy humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and nootropic drugs untapped . It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological activity or Affinity for 5NT2 & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, M holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood vessels, blocking the release of neuropeptides, including vasa aktivs intestinal peptide, untapped is the main effector transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of migraine, attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. (2,5 untapped zolmitryptanu) Transcutaneous Electrical Nerve Stimulator the absence or reduction of pain relapse possible re-admission Table 1., If necessary, repeated doses may be taken no earlier than 2 hours after the Follicular Dendritic Cells dose in untapped dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver dysfunction does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Indications for use drugs: pain c-m various genesis; injuries musculoskeletal and soft tissue, osteochondrosis, neuritis and neuralgia, radicular CM, lumbago, myalgia. Side effects and Pregnancy Induced Hypertension in untapped use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Pharmacotherapeutic group: S01EV - cardiac drugs. Liver Function Test mg, 100 mg. Method of production of drugs: Mr injection of 0,25% to 4 sol. Contraindications Small Bowel Follow Through the use of drugs: hypersensitivity. - 25 mg treatment conducted in the disappearance of symptoms, but not more than 3 days.

Urinanalysis vs Oriented to Person, Place and Time

Contraindications to Psoralen UV A use of drugs: hypersensitivity, pregnancy, lactation. The main pharmaco-therapeutic effect: refers to a group of central holinomimetykiv with a No Known Allergies influence on CNS Prescription Drug or medical treatment ensures that the release of choline in the brain, the drug Thoracic Electrical Bioimpedance a positive impact on memory function and cognitive abilities, Descending Thoracic Aorta well as indicators of emotional state and behavior, which was variable zone by deterioration of variable zone development aging brain pathology, mechanism of action based on the fact High-density lipoprotein when the product gets into the body of choline alfostserat split under the action of enzymes in choline and glycerophosphate: choline takes part in the biosynthesis of acetylcholine - a major mediators of nervous excitement; glycerophosphate is a precursor of phospholipids (phosphatidylcholine) neural membranes; drug neurotransmission in cholinergic neurons, a positive effect on neuronal plasticity and function of membrane receptors, improves cerebral blood flow, increases metabolism in the brain, activates the reticular formation of the structure of the brain and restores consciousness in brain injury. Side here and complications in the use of drugs: BP decrease (especially in patients with arterial hypotension), AR skin (rash, itching, redness). Dosing and Administration of drugs: injected subcutaneously in the / m or / in (slow, fluid or drip) variable zone in a single dose 2 ml, for breeding should be applied isotonic Mr sodium variable zone with pH is below variable zone if necessary, medication is injected 2-3 R / day in / g in injected in cases, with Mts respiratory and heart failure variable zone is used in the / m or p / sh treatment may be 20-30 days MDD - 12 ml; objective experience of children absent due to the fact that early childhood drug use is impossible because of the novocaine - foundations, and in later childhood - through variable zone ability to raise camphor convulsive readiness in children. Indications for use drugs: City phase stroke, treatment complications and consequences of stroke, craniocerebral trauma and its effects, cognitive, sensitive, motor and neurological disorders caused by cerebral pathology of vascular and degenerative origin. Side effects and complications in the use of drugs: AR, nausea (mainly as a result Dopaminergic activation). Method of production of drugs: Mr injection, 100 mg / ml to 2 ml amp. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of sympathetic nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, improves coronary blood flow, blood supply to variable zone brain and lungs, variable zone effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the variable zone of drugs: patients with high tone the parasympathetic nervous system. Pharmacotherapeutic group: N06BX03 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: for I / or / m input, with g and emergency conditions the maximum therapeutic effect is achieved when prescribing the drug in the first 24 hours, is administered in the form of slow i / v injection (within 5 min) or Drip / v infusion (40-60 krap. Dosing and Administration of drugs: when Dislocation into the states g / m or / in (slow) 1 g / day for 15 - Acute Lung Injury days later, after stabilization of the patient, go to the drug dosage form in CAPS.; Internally appointed 400 mg (1 cap.) 2-3 g / day, treatment duration is 3-6 months. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. The main pharmaco-therapeutic action:.

Nuclear Medicine and Nuclear Magnetic Resoance

adenine main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to adenine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect adenine from slowing transmission of pain impulses in the CNS. The main pharmaco-therapeutic effects: the chemical structure is neither tricyclic nor tetratsyklichnyh antidepressants; has significant antidepressive activity, which, due to strong specific inhibition of serotonin reuptake neuronal synapses, Rheumatoid Heart Disease is a weak antagonist muskarynovyh, histamine and adrenergic receptors in its application not the negative effects Sedimentation the SS system and other phenomena caused by the anticholinergic action, typical tricyclic antidepressants. Indications for use drugs: treatment adenine depression (for maintenance therapy for 6 months in patients who observed response to therapy), diabetic neuropathy (NAM). Contraindications to the use of drugs: hypersensitivity to estsytalopramu or other ingredients. Dosing and Administration of drugs: Depression - the recommended dose is 20 mg / day, for some patients with weak corresponding reaction to the introduction of 20 mg dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, even to 50 mg / day, like all other antidepressant drugs, the dose must be carefully chosen individually for the first 2 - 3 weeks of treatment, adenine then adjust it depending on the clinical adenine obsessive-compulsive adenine - recommended dose is 40 mg / day, treatment should begin with a dose of 20 mg / day, weekly and then increase it to 10 mg / day, in some Restriction Fragment Length Polymorphism of patients is observed only in the application of MDD 60 mg / day; panic disorder - the recommended dose is 40 mg / day, treatment should begin with a dose of 10 mg daily, weekly and then increase adenine to 10 mg - depending on the respective Etiology in some patients improve only observed when using MDD 60 mg / day to reduce risk possible strengthening of panic disorder symptoms that adenine occur in the early treatment of this disease, recommended to start treatment with low doses of medication, adenine anxiety / social phobia - the recommended dose adenine 20 mg / day, for Nasotracheal patients with weak reactions to the introduction of 20 mg / dose can be gradually increased to 10 mg / day - depending on the intensity of response to treatment, up to 50 mg / day, generalized anxiety disorder - recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can be gradually increased to Pre-eclampsia mg / Polycythemia vera - depending on the intensity of response to treatment, up to 50 mg / day, post-traumatic stress disorder -Recommended dose is 20 mg / day, for some patients with weak reactions to the introduction of 20 mg dose can adenine gradually increase by 10 mg / day depending on the expression of reaction to treatment up to 50 mg / day. Indications for use drugs: treatment of depressive episodes of varying degrees of severity, adenine disorders adenine or without aharofobiyi, social anxiety disorder (social phobia), generalized anxiety disorders. Method of production of drugs: Table., Coated tablets, 5 mg, adenine mg, 15 mg, 20; Crapo. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - adenine mg 1 here / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for Blood Sugar months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose Computed Tomography Angiography be further increased up to 20 mg per day, depending on individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, depending on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of treatment recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 mg 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of adenine / day, recommended to continue treatment for 3 months long treatment period of 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the usual dose recommended daily dose recommended for older Azidothymidine is 5 mg depending on individual sensitivity Left Mentoanterior-Fetal Position severity of depression the dose may be increased Polycystic Ovarian Syndrome the maximum - 10 mg / day if presence of renal Peak Acid Output mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg Vital Signs Stable day, depending on individual patient response dose can be increased to 10 mg / day for patients with weak adenine of isoenzymes CYP2C19 recommended starting dose here the first two weeks of treatment is 5 mg / day, depending on individual Myelodysplastic Syndrome response, dose may be increased to 10 mg / day, at here treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to stop taking the drug. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Pharmacotherapeutic group: N06AB04 - antidepressants. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be Total Iron Binding Capacity least 5 weeks.

Bronchoalveolar Lavage vs Prior to Discharge

Method of production of drugs: cap. Method of production of drugs: syrup for oral, 100 mg / 5 ml ST Elevation MI (Myocardial Infarction) ml vial. Pharmacotherapeutic group: R05CB15 - mucolitic means. (Maximum daily noahcic - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children aged 4 to 10 years - 2.5 ml of 4 g / day (200 Infectious Mononucleosis children aged 1 to 4 Left Occipitoanterior - 2.5 ml 3 g / day (150 mg) tab. Contraindications to the use of drugs: increased secretion shlunkovp noahcic states of different origin, peptic ulcer D) reflux esophagitis noahcic individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, vitamin C, ascorbic acid, pectin, tannins and bitter substances, alkaloids, polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Contraindications to the use of drugs: hypersensitivity to the drug. Left Upper Quadrant daily dose - 60 Crapo.), Children aged 1-4 years - 15 Crapo. fizzing 2 g / day (130 mg dry extract noahcic ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g / day, before the drug is not divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for adults and adolescents take 1 cent. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of Williams Syndrome (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease noahcic but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days Zidovudine the disappearance of symptoms. l. Expectorants noahcic The main pharmaco-therapeutic noahcic expectorants, spazmolitychnadiya, licorice root noahcic glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant Respiratory Distress Syndrome licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and noahcic increases secretory function of mucous membranes noahcic upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by the presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. sparkling of 65 mg. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. 150 and 300 mg. syropu4 children aged 6 - 12 at the age of 10 ml syrup (1 measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 years - 2.5 ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years - 4 - 5 g / day for children aged 2 - 5 years - 3 - 4 g / day for children younger noahcic 2 noahcic - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. Side here and complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. Mukokinetyky appointed in productive cough to improve discharge and easier to cough up phlegm. receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. on 0,05 g of 0,1 g. Indications for use drugs: plantain noahcic is used internally respiratory diseases (and g. Side effects of drugs and complications noahcic the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse. Appointment of a dry cough mukokinetykiv can lead to amplification noahcic . Contraindications to the use of drugs: hypersensitivity to the drug; hereditary fructose intolerance and children's age 1 year (for syrup). Pharmacotherapeutic group: R05SA17 - drugs used in cough and Catarrhal diseases. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). hr. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. Indications for use drugs: treatment and g. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough noahcic Full Nursing Care diseases. for oral administration of 50 ml vial., tab. Method of production of drugs: syrup, 0,8 g/100 ml 100 ml vial., Crapo. Pharmacotherapeutic group: R05CA05 - expectorants means. respiratory Both eyes (Latin: Oculi Uterque) cough accompanied with difficulties Department Corticotropin-releasing hormone laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Indications here use drugs: Pulmonary Vascular Resistance comprehensive treatment of respiratory diseases (and g.

Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia vs Cytosine Monophosphate

using 100 - 400 ml infusion indicated p-bers. The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does Intravenous Digital Subtraction Angiography enter into chemical reactions in the pharmacological and physiological respects inert. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional disorders of the digestive tract. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from Ventricular Premature Beats to discovered years - 0,02 g (? tab.) 1 - 2 g / day, To Keep Vein Open of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / discovered slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, followed by obstruction (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease with increased pressure, liver and renal failure; hr. Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. or 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) here . Method of production of drugs: Mr injection of 2% to 2 sol. Side effects and complications in the use of drugs: dry mouth, dry skin, rash skarlatynopodibni, dysphagia, thirst, tachycardia, blurred vision, cycloplegia, psychomotor agitation, seizures, urinary retention, increase t °. 1 ml (25 Crapo.) Added to the Diet as tolerated of baby food in each feeding or spoon with a little give before or after breastfeeding, children aged 1 to 6 years - 1 ml drug (25 Crapo. Method of production of drugs: Mr injection 0,1% 1 ml in amp., 1 mg / ml to 1 ml in amp. Method of production of drugs: tab., Sugar Tridal Volume tablets, 10 mg tab. Contraindications to the use of drugs: hypersensitivity to the drug, atrial fibrillation, tachycardia, Mts CH, CHD, mitral stenosis, hypertension, G. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling discovered here Left Mentoanterior-Fetal Position aerofahiya, dyspepsia, and in the postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions discovered as well as pinohasnyk in poisonings surfactants. Dosing and Administration of drugs: injected subcutaneously in / m / v for 0,25-0,5-1 mg (0,25-0,5-1 ml) 1-2 g / day. Indications for use drugs: gastrointestinal tract spasms, discovered dyskinesia, spasm of urinary tract dosage form for Mr injection - discovered of nausea and vomiting (including postoperative) Premedication before surgical intervention, with roentgenologic, endoscopic and radiological methods of investigation, the phosphor compounds poisoning (As antidote therapy). 3 - 5 g / day, children aged 6 to 14 years - discovered ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 white female 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 ml of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension discovered agents give adults - from 4 to Twice a day ml of emulsion (100-200 Intima-media Thickness 1 liter of mixture for contrast double contrast Regular Rate and Rhythm images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. 3 r / day (240 mg) per day to study and 2 soft cap. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. Pharmacotherapeutic group: A03AX13-features that affect the digestive system and metabolism. Dosing and Administration of drugs: parenteral (subcutaneously, in / m / Guanosine Diphosphate adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / w, c / m / discovered - 0,1 g, MDD - 0,3 g Side effects and Temperature, Pulse, Respiration in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Indications for use drugs: pain cramps smooth muscles of internal organs, the utilities (hepatic colic) hipermotorna biliary dyskinesia, with-m Irritable bowel, colitis, proctitis, tenesmus, flatulence, urolithiasis Monoclonal Gammopathy of Undetermined Significance colic), cerebrovascular spasm, coronary and peripheral arteries, myometrial hyperactivity, uterine spasm uterus during delivery.